India Pharm Firms Say Price Controls Dampening Hiring
This article was originally published in PharmAsia News
Recent Indian regulatory action capping the prices of hundreds of drugs has led to a recruiting slowdown within the pharma industry, in a country experiencing a general hiring surge.
You may also be interested in...
Sanofi has received formal approval from the European Commission for its insulin aspart biosimilar.
Europe's self-care industry urges the European Commission to use Rx-to-OTC switch and real world evidence to widen access to OTC medicines in the region as part of its new pharmaceutical strategy.
Procter & Gamble failed to substantiate claims that Vicks First Defence can eliminate cold symptoms completely, says UK ad regulator ASA.